Financial Incentives for Smoking Cessation

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00128375
First received: August 8, 2005
Last updated: December 12, 2007
Last verified: December 2007
  Purpose

The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.


Condition Intervention
Tobacco Use Disorder
Behavioral: Financial incentives

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Financial Incentives for Smoking Cessation

Resource links provided by NLM:


Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • Biochemically verified smoking cessation rates at 6 months post-quit date

Secondary Outcome Measures:
  • Enrollment in and completion of community-based smoking cessation programs within the first 6 months after randomization
  • Short-term quit rates at 3 months or 6 months post-quit date
  • Quit rates at 12 months post-quit date

Estimated Enrollment: 878
Study Start Date: March 2005
Estimated Study Completion Date: April 2008
Detailed Description:

Smoking is the leading cause of preventable mortality in United States, accounting for approximately 435,000 of the 2.4 million deaths each year in the United States. Most smokers make multiple attempts to quit smoking, but only 2-3% succeed each year. Smoking cessation programs have proven effective in helping smokers quit, but only about 5% of smokers enroll in smoking cessation programs each year.

Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates, but have not been well tested as a mechanism for increasing long-term quit rates. The existing evidence suggests that they could be highly effective, particularly among heavy smokers and low income smokers. In addition, financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments.

This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the U.S. Smokers will be randomized to receive either usual care (information about local community-based smoking cessation resources, coverage of prescription drugs and physician visits) or usual care plus a package of financial incentives that includes $100 for completion of a community-based tobacco cessation program, $250 for short-term smoking cessation at either 3 months or 6 months after randomization, and $400 for smoking cessation 6 months post-quit date (biochemically confirmed).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Employees of General Electric at work sites in the United States
  • Current smokers who report having smoked at least 5 cigarettes per day for the prior 12 months
  • Age 18 or older

Exclusion Criteria:

  • Current use of other tobacco products, such as chewing tobacco, pipes, or cigars
  • Planning to leave General Electric within the next 18 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00128375

Locations
United States, Pennsylvania
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States, 19104-6021
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: Kevin G Volpp, MD, PhD University of Pennsylvania
  More Information

No publications provided by University of Pennsylvania

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00128375     History of Changes
Other Study ID Numbers: 802295, 1-R01-DP-000100-03
Study First Received: August 8, 2005
Last Updated: December 12, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pennsylvania:
Smoking Cessation
Work-site
Incentives
Cost Effectiveness
Health Behavior
Smoking

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 26, 2014